Condition
Locally Advanced Non Small Cell Lung Cancer
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Unknown3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06066138Phase 1Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
NCT05111197Phase 3UnknownPrimary
Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy
NCT03741647UnknownPrimary
Sleep Apnea and Lung Cancer
NCT03886441Phase 2UnknownPrimary
Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate
Showing all 4 trials